Inventor · disambiguated record
Alain Tedgui
Also filed as: TEDGUI ALAIN
14 granted patents·18 pending applications·12 citations·filing 2001–2022
86Inventor score
Top patents by PatentIndex Score
32 records- 0177US8361732B2Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventINST NAT SANTE RECH MED·Filed 2012·Granted Jan 29, 2013·2 cites·4 claims
- 0273US8383355B2Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventINST NAT SANTE RECH MED·Filed 2009·Granted Feb 26, 2013·3 cites·15 claims
- 0373US8324152B2Composition for the treatment of atherosclerosisTEDGUI ALAIN·Filed 2006·Granted Dec 4, 2012·3 cites·7 claims
- 0467US8163504B2Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventMALLAT ZIAD·Filed 2009·Granted Apr 24, 2012·2 cites·10 claims
- 0566US12144859B2B cell depleting agent for the treatment of atherosclerosisMALLAT ZIAD·Filed 2020·Granted Nov 19, 2024·0 cites·10 claims
- 0664US9688767B2Method of predicting survival time in myocardial infarction patients by measuring BAFF levelsINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE·Filed 2014·Granted Jun 27, 2017·1 cites·3 claims
- 0760US9193971B2Methods for the treatment of nonalcoholic steatohepatitisINST NAT SANTE RECH MED·Filed 2013·Granted Nov 24, 2015·1 cites·5 claims
- 0857US2019365890A1A B Cell Depleting Agent for the Treatment of AtherosclerosisMALLAT ZIAD·Filed 2019·Application pending·0 cites
- 0956US2013224215A1A B Cell Depleting Agent for the Treatment of AtherosclerosisMALLAT ZIAD·Filed 2013·Application pending·0 cites
- 1054US8586822B2Methods for producing a non human model for aortic aneurysmTHARAUX PIERRE LOUIS·Filed 2008·Granted Nov 19, 2013·0 cites·10 claims
- 1154US2024376172A1Interleukin 2 chimeric constructs with targeting specificy to inflamed tissuesILTOO PHARMA·Filed 2022·Application pending·0 cites
- 1249US9592267B2Use of IL-18BP for treatment of peripheral vascular diseasesCHVATCHKO YOLANDE·Filed 2003·Granted Mar 14, 2017·0 cites·23 claims
- 1349US2015104463A1Methods and kits for predicting the risk of having a cardiovascular event in a subjectMALLAT ZIAD·Filed 2014·Application pending·0 cites
- 1448US2014288156A1Methods for the treatment and diagnosis of atherosclerosisINST NAT SANTE RECH MED·Filed 2012·Application pending·0 cites
- 1547US2007116674A1Use of adipose tisue cells for initiating the formation of a fuctional vascular networkCASTEILLA LOUIS·Filed 2004·Application pending·0 cites
- 1646US2011275791A1A B Cell Depleting Agent for the Treatment of AtherosclerosisMALLAT ZIAD·Filed 2010·Application pending·0 cites
- 1746US2007249008A1Cardiovascular Prognostic and Diagnostic MarkerMALLAT ZIAD·Filed 2005·Application pending·0 cites
- 1845US9566313B2Method of treating peripheral vascular diseases using IL-18 inhibitorsCHVATCHKO YOLANDE·Filed 2010·Granted Feb 14, 2017·0 cites·6 claims
- 1944US8187818B2Use of sPLA2 activity for the diagnosis of a cardiovascular eventTEDGUI ALAIN·Filed 2007·Granted May 29, 2012·0 cites·9 claims
- 2044US7985409B2Tr1 cells for use in atherosclerosisINST NAT SANTE RECH MED·Filed 2004·Granted Jul 26, 2011·0 cites·17 claims
- 2143US9573997B2Method for use in the treatment of aneurysmINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2013·Granted Feb 21, 2017·0 cites·1 claims
- 2243US2012321650A1Composition for the treatment of atherosclerosisTEDGUI ALAIN·Filed 2012·Application pending·0 cites
- 2342US11752131B2Methods and pharmaceutical compositions for the treatment of obesityINST NAT SANTE RECH MED·Filed 2017·Granted Sep 12, 2023·0 cites·6 claims
- 2442US2016054338A1Methods for Predicting Cardiovascular Mortality RiskBOULANGER CHANTAL·Filed 2015·Application pending·0 cites
- 2542US2012116817A1Methods for Predicting Cardiovascular Mortality RiskBOULANGER CHANTAL·Filed 2010·Application pending·0 cites
- 2642US2015297628A1Methods for the treatment and diagnosis of atherosclerosisINST NAT SANTE RECH MED·Filed 2015·Application pending·0 cites
- 2742US2004076628A1Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosisFiled 2001·Application pending·0 cites
- 2841US2014004540A1Methods and kits for predicting the risk of having a cardiovascular event in a subjectMALLAT ZIAD·Filed 2012·Application pending·0 cites
- 2939US2012207722A1Use Of Adipose Tissue Cells For Initiating The Formation Of A Functional Vascular NetworkCASTEILLA LOUIS·Filed 2012·Application pending·0 cites
- 3039US2010256045A1Use of Measles Virus Nucleoprotein for Treating AtherosclerosisMALLAT ZIAD·Filed 2007·Application pending·0 cites
- 3137US2015299763A1Spla2 cardiovascular prognostic and diagnostic markerI N S E R M INST NAT DE LA SANTE ET DE LA RECH MEDICALE·Filed 2015·Application pending·0 cites
- 3225US2012076754A1Use of IL-17 Polypeptides for Use in the Prevention or Treatment of AtherosclerosisMALLAT ZIAD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alain Tedgui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →